| For: | Maletzki C, Gock M, Klier U, Klar E, Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 2010; 16(28): 3546-3552 [PMID: 20653063 DOI: 10.3748/wjg.v16.i28.3546] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i28/3546.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Jingran Ji, Woo Ram Park, Soojeong Cho, Yihe Yang, Weiguo Li, Kathleen Harris, Xiaoke Huang, Shangzhi Gu, Dong-Hyun Kim, Zhuoli Zhang, Andrew C. Larson. Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging–Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models. Journal of Vascular and Interventional Radiology 2019; 30(7): 1106 doi: 10.1016/j.jvir.2018.11.002
|
| 3 |
Guoying Ni, Tianfang Wang, Lin Yang, Yuejian Wang, Xiaosong Liu, Ming Q. Wei. Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management. Human Vaccines & Immunotherapeutics 2016; 12(3): 599 doi: 10.1080/21645515.2015.1089008
|
| 4 |
M A Suvorova, T A Kramskaja, A B Karaseva, V N Mukhin, E I Ermolenko, A N Suvorov. THE INACTIVATION OF THE GENE OF ARGININE DEIMINAZE OF STREPTOCOCCI REDUCES THE DEGREE OF THEIR ANTINEOPLASTIC ACTIVITY IN THE COURSE OF IN VITRO AND IN VIVO EXPERIMENTS. Medical academic journal 2017; 17(1): 96 doi: 10.17816/MAJ17196-101
|
| 5 |
Ulrike Klier, Claudia Maletzki, Bernd Kreikemeyer, Ernst Klar, Michael Linnebacher. Combining bacterial-immunotherapy with therapeutic antibodies: A novel therapeutic concept. Vaccine 2012; 30(17): 2786 doi: 10.1016/j.vaccine.2012.01.071
|
| 6 |
Frank T. Wen, Ronald A. Thisted, Donald A. Rowley, Hans Schreiber. A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth. OncoImmunology 2012; 1(2): 172 doi: 10.4161/onci.1.2.18311
|
| 7 |
Atieh Yaghoubi, Kiarash Ghazvini, Majid Khazaei, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour. The use of Clostridium in cancer therapy: a promising way. Reviews and Research in Medical Microbiology 2022; 33(2): 121 doi: 10.1097/MRM.0000000000000281
|
| 8 |
Rosa Behboodi, Arman Saadati Partan, Sepideh Meidaninikjeh, Yasamin Morvarid, Haniyeh Sadat Hosseininia, Maryam Sayhinouri, Armaghan Shirinsokhan, Sahar Javadi, Amin Ebrahimi Sadrabadi, Arsalan Jalili. Clostridium Bacteria: The Team of Microscopic Oncologists. Iranian Journal of Blood and Cancer 2023; 15(4): 178 doi: 10.61186/ijbc.15.4.178
|
| 9 |
Shuping Li, Hua Yue, Shuang Wang, Xin Li, Xiaojun Wang, Peilin Guo, Guanghui Ma, Wei Wei. Advances of bacteria-based delivery systems for modulating tumor microenvironment. Advanced Drug Delivery Reviews 2022; 188: 114444 doi: 10.1016/j.addr.2022.114444
|
| 10 |
Van Anh Thi Nguyen, Hong Anh Huynh, Tong Van Hoang, Ngoc Thi Ninh, An Thi Hong Pham, Hoa Anh Nguyen, Tuan-Nghia Phan, Simon M. Cutting. KilledBacillus subtilisspores expressing streptavidin: a novel carrier of drugs to target cancer cells. Journal of Drug Targeting 2013; 21(6): 528 doi: 10.3109/1061186X.2013.778262
|
| 11 |
Amy E. DeClue, Sandra M. Axiak-Bechtel, Yan Zhang, Saurabh Saha, Linping Zhang, David D. Tung, Jeffrey N. Bryan. Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy. BMC Veterinary Research 2018; 14(1) doi: 10.1186/s12917-018-1424-1
|
| 12 |
Guoying Ni, Yong Wang, David Good, Jianwei Yuan, Xuan Pan, Jou Wei, Xiaosong Liu, Ming Q. Wei. The Dosage of the Derivative ofClostridium Ghonii(DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγResponse Is Elicited in TC-1 Tumour Bearing Mice. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1395138
|
| 13 |
Alexandra M. Mowday, Jella M. van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Dubois, Philippe Lambin, Jan Theys, Adam V. Patterson. Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?. Critical Reviews in Microbiology 2024; 50(6): 955 doi: 10.1080/1040841X.2024.2311653
|
| 14 |
Sun-Young Chang, Yeon-Jeong Kim, Hyun-Jeong Ko. Potential therapeutic anti-tumor effect of aSalmonella-based vaccine. Human Vaccines & Immunotherapeutics 2013; 9(8): 1654 doi: 10.4161/hv.24917
|
| 15 |
Saskia Stier, Claudia Maletzki, Ulrike Klier, Michael Linnebacher. Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/271246
|
| 16 |
Verena Staedtke, Nicholas J. Roberts, Ren-Yuan Bai, Shibin Zhou. Clostridium novyi-NT in cancer therapy. Genes & Diseases 2016; 3(2): 144 doi: 10.1016/j.gendis.2016.01.003
|
| 17 |
Piyush Baindara, Suresh Korpole, Vishakha Grover. Bacteriocins: perspective for the development of novel anticancer drugs. Applied Microbiology and Biotechnology 2018; 102(24): 10393 doi: 10.1007/s00253-018-9420-8
|
| 18 |
Sergio Rius-Rocabert, Francisco Llinares Pinel, Maria Jose Pozuelo, Antonia García, Estanislao Nistal-Villan. Oncolytic bacteria: past, present and future. FEMS Microbiology Letters 2019; 366(12) doi: 10.1093/femsle/fnz136
|
| 19 |
M A Suvorova, A N Tsapieva, N V Duplik, T A Kramskaya, K B Grabovskaya, E P Kiseleva, V A Chereshnev, A N Suvorov. KONSTRUIROVANIE ShTAMMA STREPTOKOKKA, MUTANTNOGO PO GENU M-BELKA. Medical academic journal 2016; 16(4): 235 doi: 10.17816/MAJ164235-236
|
| 20 |
Linfeng Zheng, Zhuoli Zhang, Khashayarsha Khazaie, Saurabh Saha, Robert J. Lewandowski, Guixiang Zhang, Andrew C. Larson, Bing Xu. MRI-Monitored Intra-Tumoral Injection of Iron-Oxide Labeled Clostridium novyi-NT Anaerobes in Pancreatic Carcinoma Mouse Model. PLoS ONE 2014; 9(12): e116204 doi: 10.1371/journal.pone.0116204
|
| 21 |
Li Wang, Qing Wang, Xiaochao Tian, Xinli Shi. Learning from Clostridium novyi-NT. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S1 doi: 10.4103/0973-1482.204841
|
| 22 |
Michael Linnebacher, Claudia Maletzki, Ulrike Klier, Ernst Klar. Bacterial immunotherapy of gastrointestinal tumors. Langenbeck's Archives of Surgery 2012; 397(4): 557 doi: 10.1007/s00423-011-0892-6
|
| 23 |
Xin Zhang, Yang Zhang, Ning Wang, Yetong Shen, Qing Chen, Lu Han, Bo Hu. Photothermal Nanoheaters-Modified Spores for Safe and Controllable Antitumor Therapy. International Journal of Nanomedicine 2022; : 6399 doi: 10.2147/IJN.S385269
|
